N/A N=4 Basic Science

Effect of Daily Low Dose Aspirin on Exhaled Inflammatory Mediators in Normal Subjects

Healthy

Bottom Line

View on ClinicalTrials.gov: NCT00898222 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2014

Primary outcome: Primary: Change in Exhaled Inflammatory Mediator Levels — 1.42 pg/mL

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: aspirin (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Brigham and Women's Hospital
Primary completion: Aug 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Exhaled Inflammatory Mediator Levels	1.42	—

Summary

Hypothesis: Low dose aspirin does not change exhaled inflammatory breath mediators in normal subjects.

Eligibility Criteria

Inclusion Criteria

healthy adults

Exclusion Criteria

any underlying major medical conditions such as heart disease, hypertension, stroke, diabetes, bleeding disorders

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00898222). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.